Simplex Trading’s Shattuck Labs STTK Stock Holding History

Simplex Trading’s Portfolio STTK Stock Details STTK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q2	–	Sell	-11,100	Closed	-$99K	–	9779
2024 Q1	$99K	Sell	11,100 -67,200	-86%	-$615K	﹤0.01%	5591
2023 Q4	$558K	Buy	+78,300	New	+$214K	﹤0.01%	3578

Other funds holding STTK

T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return

OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return

Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return

Prosight Management Dallas, Texas $610M AUM 40.86% 1-Year Est. Return

Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return

NCM

NEXTBio Capital Management Menlo Park, California $215M AUM

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

CEI

Clark Estates Inc New York $416M AUM 6.04% 1-Year Est. Return

Pinnacle Associates New York $7.78B AUM 45.07% 1-Year Est. Return

Simplex Trading's STTK Position: Q3 2025 in Review

Simplex Trading sold out of Shattuck Labs (STTK) in Q3 2025, closing a stake of 1,156 shares — an estimated $1.41K sold.

Simplex Trading first reported a position in STTK in Q2 2022 and held it in 9 quarters. The position peaked at $69K in Q1 2024. 56 funds tracked by Wall St. Rank hold STTK as of Q3 2025.

Simplex Trading reported no remaining Shattuck Labs position as of Q3 2025 after selling out during the quarter.
Simplex Trading sold 1,156 Shattuck Labs shares in Q3 2025, an estimated $1.41K.
Simplex Trading first reported a position in Shattuck Labs in Q2 2022 and held it in 9 quarters.
Simplex Trading's Shattuck Labs position peaked at $69K in Q1 2024.
56 funds tracked by Wall St. Rank held Shattuck Labs as of Q3 2025.

Based on Simplex Trading's 13F filing for Q3 2025, filed 12 Nov 2025.